Biogen Inc. (BIIB) vs Lufax Holding Ltd (LU)
BIIB leads on 9 of 13 compared metrics.
A side-by-side comparison of Biogen Inc. and Lufax Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIIB vs LU
growth of $100 · last 6yBIIB -20.6%LU -97.4%BIIB compounded faster
Log scale — wide-divergence pair
BIIB LU
BIIB vs LU: by the numbers
- •BIIB is the larger company ($29.53B vs $558M market cap).
- •BIIB is profitable (13.92% net margin) while LU runs a net loss (-10.59%).
- •BIIB grew revenue faster over the past five years (-4.80% vs -6.44% CAGR).
Which is better, BIIB or LU?
Metric tally: BIIB 9 · LU 4It depends on what you're optimizing for:
GrowthBIIB(faster 5Y revenue CAGR)
QualityBIIB(higher ROIC)
Valuation
| Metric | BIIB | LU |
|---|---|---|
| P/E ratio | 21.42 | — |
| Forward P/E | 12.23 | — |
| P/S ratio | 3.01 | 0.09● |
| P/B ratio | 1.59 | 0.05● |
| EV / EBITDA | 12.16● | 72.98 |
| FCF yield | 8.83% | 312.50%● |
Profitability
| Metric | BIIB | LU |
|---|---|---|
| Gross margin | 69.77%● | 41.96% |
| Operating margin | 15.65%● | -4.31% |
| Net margin | 13.92%● | -10.59% |
| ROE | 7.36%● | -4.14% |
| ROIC | 6.62%● | -0.21% |
Growth (annualized)
| Metric | BIIB | LU |
|---|---|---|
| Revenue CAGR (5Y) | -4.80%● | -6.44% |
| EPS CAGR (5Y) | -18.67%● | -43.16% |
| FCF CAGR (5Y) | -3.59% | 24.09%● |
| Total return CAGR (5Y) | -12.79%● | -40.92% |
Frequently asked
- Which is better, BIIB or LU?
- It depends on your goal. growth: BIIB (faster 5Y revenue CAGR); quality: BIIB (higher ROIC). Across all compared metrics, BIIB leads 9 to 4.
- Which has grown faster, BIIB or LU?
- Over the past five years, BIIB grew revenue faster — BIIB at a -4.80% CAGR versus LU at -6.44%.
- Is BIIB or LU more profitable?
- BIIB runs the higher net margin — BIIB at 13.92% versus LU at -10.59%.
- Which has been the better investment, BIIB or LU?
- Over the past 5-year, BIIB delivered the higher annualized total return — BIIB at -2.05% versus LU at -40.92%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioLufax P/E ratioBiogen dividend yieldLufax dividend yieldBiogen ROELufax ROEBiogen operating marginLufax operating marginBiogen revenue growthLufax revenue growthBiogen free cash flowLufax free cash flow
Biogen & Lufax appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.